First Merchants Corp’s Bristol-Myers Squibb BMY Stock Holding History

First Merchants Corp’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,050	Closed	-$247K	–	371
2025 Q1	$247K	Sell	4,050 -27,047	-87%	-$1.58M	0.01%	330
2024 Q4	$1.76M	Buy	31,097 +45	+0.1%	+$2.51K	0.07%	182
2024 Q3	$1.61M	Sell	31,052 -115	-0.4%	-$5.39K	0.06%	190
2024 Q2	$1.29M	Buy	31,167 +27,010	+650%	+$1.21M	0.05%	198
2024 Q1	$225K	Buy	4,157 +17	+0.4%	+$866	0.02%	209
2023 Q4	$212K	Hold	4,140	–	–	0.02%	203
2023 Q3	$240K	Sell	4,140 -1,808	-30%	-$111K	0.02%	194
2023 Q2	$380K	Sell	5,948 -225	-4%	-$15.1K	0.03%	182
2023 Q1	$428K	Sell	6,173 -269	-4%	-$19K	0.04%	182
2022 Q4	$463K	Buy	6,442 +1,400	+28%	+$106K	0.04%	179
2022 Q3	$358K	Buy	5,042 +777	+18%	+$56.4K	0.04%	195
2022 Q2	$328K	Sell	4,265 -275	-6%	-$20.9K	0.03%	198
2022 Q1	$332K	Sell	4,540 -137	-3%	-$9.2K	0.03%	206
2021 Q4	$292K	Sell	4,677 -720	-13%	-$42.2K	0.02%	215
2021 Q3	$319K	Buy	5,397 +820	+18%	+$54K	0.02%	220
2021 Q2	$306K	Sell	4,577 -26,689	-85%	-$1.74M	0.02%	220
2021 Q1	$1.97M	Buy	+31,266	New	+$1.95M	0.13%	140
2018 Q4	–	Sell	-4,375	Closed	-$272K	–	197
2018 Q3	$272K	Hold	4,375	–	–	0.04%	195
2018 Q2	$242K	Sell	4,375 -2,500	-36%	-$135K	0.04%	198
2018 Q1	$435K	Buy	6,875 +80	+1%	+$5.15K	0.07%	169
2017 Q4	$417K	Sell	6,795 -775	-10%	-$48.5K	0.07%	178
2017 Q3	$482K	Sell	7,570 -1,090	-13%	-$63.6K	0.08%	172
2017 Q2	$482K	Sell	8,660 -600	-6%	-$32.6K	0.13%	123
2017 Q1	$503K	Sell	9,260 -382	-4%	-$21K	0.14%	123
2016 Q4	$563K	Buy	9,642 +763	+9%	+$41.7K	0.17%	116
2016 Q3	$479K	Sell	8,879 -163	-2%	-$10.5K	0.15%	119
2016 Q2	$665K	Sell	9,042 -42	-0.5%	-$2.97K	0.22%	110
2016 Q1	$581K	Sell	9,084 -423	-4%	-$26.7K	0.21%	107
2015 Q4	$654K	Sell	9,507 -200	-2%	-$13.2K	0.23%	109
2015 Q3	$575K	Sell	9,707 -320	-3%	-$20.3K	0.21%	113
2015 Q2	$667K	Sell	10,027 -1,280	-11%	-$84.4K	0.21%	109
2015 Q1	$729K	Hold	11,307	–	–	0.23%	104
2014 Q4	$667K	Sell	11,307 -8,125	-42%	-$458K	0.21%	102
2014 Q3	$995K	Buy	19,432 +7,675	+65%	+$383K	0.32%	93
2014 Q2	$570K	Sell	11,757 -385	-3%	-$19K	0.18%	111
2014 Q1	$631K	Sell	12,142 -2,157	-15%	-$115K	0.2%	106
2013 Q4	$760K	Sell	14,299 -571	-4%	-$29.1K	0.25%	102
2013 Q3	$688K	Sell	14,870 -100	-0.7%	-$4.39K	0.23%	104
2013 Q2	$669K	Buy	+14,970	New	+$650K	0.24%	100

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Merchants Corp's BMY Position: Q2 2025 in Review

First Merchants Corp sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 4,050 shares — an estimated $247K sold.

First Merchants Corp first reported a position in BMY in Q2 2013 and held it in 39 quarters. The position peaked at $1.97M in Q1 2021. 2,292 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

First Merchants Corp reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
First Merchants Corp sold 4,050 Bristol-Myers Squibb shares in Q2 2025, an estimated $247K.
First Merchants Corp first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 39 quarters.
First Merchants Corp's Bristol-Myers Squibb position peaked at $1.97M in Q1 2021.
2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on First Merchants Corp's 13F filing for Q2 2025, filed 23 Jul 2025.